Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway

BACKGROUND: Mesenchymal stem cells (MSCs) are promising candidates for tissue regeneration and disease treatment. However, long-term in vitro passaging leads to stemness loss of MSCs, resulting in failure of MSC therapy. This study investigated whether the combination of melatonin and human umbilica...

Descripción completa

Detalles Bibliográficos
Autores principales: Aierken, Aili, Li, Balun, Liu, Peng, Cheng, Xuedi, Kou, Zheng, Tan, Ning, Zhang, Mengfei, Yu, Shuai, Shen, Qiaoyan, Du, Xiaomin, Enkhbaatar, Bold Bayar, Zhang, Juqing, Zhang, Rui, Wu, Xiaolong, Wang, Ruibin, He, Xin, Li, Na, Peng, Sha, Jia, Wenwen, Wang, Congrong, Hua, Jinlian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006413/
https://www.ncbi.nlm.nih.gov/pubmed/35414044
http://dx.doi.org/10.1186/s13287-022-02832-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006413/
https://www.ncbi.nlm.nih.gov/pubmed/35414044
http://dx.doi.org/10.1186/s13287-022-02832-0

Ejemplares similares